We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

102 hedge funds and large institutions have $405M invested in VanEck Pharmaceutical ETF in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

392% more call options, than puts

Call options by funds: $551K | Put options by funds: $112K

44% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 25

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

3% more capital invested

Capital invested by funds: $392M → $405M (+$12.6M)

0% more funds holding

Funds holding: 102 → 102 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

12.44% less ownership

Funds ownership: 107.35% → 94.91% (-12%)

Holders
102
Holders Change
–
Holders Change %
0%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
36
Reduced
25
Closed
13
Calls
$551K
Puts
$112K
Net Calls
+$439K
Net Calls Change
-$87K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$42.9M
2
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$12.3M
3
JP Morgan Chase
JP Morgan Chase
New York
+$12.1M
4
IAA
Independent Advisor Alliance
North Carolina
+$3.96M
5
Morgan Stanley
Morgan Stanley
New York
+$2.34M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$27.9M
2
PF
Phoenix Financial
Israel
-$22.8M
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$12M
4
HighTower Advisors
HighTower Advisors
Illinois
-$3.71M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$2.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$1.85M -$2.51M -31,128 -57%
EH
27
Equitable Holdings
New York
$1.65M +$882K +10,940 +113%
Commonwealth Equity Services
28
Commonwealth Equity Services
Massachusetts
$1.51M +$34K +422 +2%
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
$1.48M +$878K +10,888 +143%
TRCT
30
Tower Research Capital (TRC)
New York
$1.32M +$724K +8,975 +119%
National Bank of Canada
31
National Bank of Canada
Quebec, Canada
$1.21M -$16.9K -209 -1%
AWS
32
Atria Wealth Solutions
New York
$1.15M +$894K +11,088 +336%
Osaic Holdings
33
Osaic Holdings
Arizona
$1.08M +$280K +3,470 +34%
GCP
34
GSA Capital Partners
United Kingdom
$1.05M +$119K +1,480 +13%
PPG
35
Peak Planning Group
Colorado
$970K -$12.5K -155 -1%
AWM
36
Axxcess Wealth Management
California
$969K – – –
Cohen & Steers
37
Cohen & Steers
New York
$938K – – –
UBS Group
38
UBS Group
Switzerland
$872K -$122K -1,516 -12%
Stifel Financial
39
Stifel Financial
Missouri
$859K -$53.9K -669 -6%
CAN
40
Cetera Advisor Networks
California
$753K +$111K +1,373 +17%
Neuberger Berman Group
41
Neuberger Berman Group
New York
$750K +$389K +4,825 +105%
Jane Street
42
Jane Street
New York
$739K +$514K +6,374 +221%
Renaissance Technologies
43
Renaissance Technologies
New York
$735K +$371K +4,600 +100%
OC
44
Oppenheimer & Co
New York
$703K -$1.65M -20,438 -70%
WI
45
Wintrust Investments
Illinois
$662K – – –
Marshall Wace
46
Marshall Wace
United Kingdom
$621K +$627K +7,776 New
Millennium Management
47
Millennium Management
New York
$617K +$623K +7,729 New
SPIA
48
Steward Partners Investment Advisory
New York
$568K -$162K -2,006 -22%
TWM
49
Tradition Wealth Management
Minnesota
$544K – – –
Envestnet Asset Management
50
Envestnet Asset Management
Illinois
$468K +$69K +856 +17%
1
2
3 4 5

PPH Hedge Fund Activity: Q3 2023 in Review

102 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q3 2023, worth a combined $405M — up 3.2% from $392M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new PPH positions and 13 closed out — a net gain of 1 holder — while 36 added to existing stakes and 25 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $42.9M. The largest seller was Bank of America, cutting an estimated $27.9M.

  • 102 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $405M of VanEck Pharmaceutical ETF stock for Q3 2023, up 3.2% quarter-over-quarter.
  • 14 funds opened new VanEck Pharmaceutical ETF positions in Q3 2023 and 13 closed out, a net change of +1 holder.
  • The largest VanEck Pharmaceutical ETF buyer in Q3 2023 was Goldman Sachs, an estimated $42.9M added.
  • The largest VanEck Pharmaceutical ETF seller in Q3 2023 was Bank of America, an estimated $27.9M sold.

Based on aggregated 13F filings for Q3 2023.